↓ Skip to main content

Why COVID vaccines for young children (5–11 years) are not essential at this moment in time?

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, March 2022
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#4 of 527)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news
11 news outlets
twitter
215 X users
facebook
1 Facebook page

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Why COVID vaccines for young children (5–11 years) are not essential at this moment in time?
Published in
Journal of Pharmaceutical Policy and Practice, March 2022
DOI 10.1186/s40545-022-00424-0
Pubmed ID
Authors

Hamid A. Merchant

X Demographics

X Demographics

The data shown below were collected from the profiles of 215 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 24%
Researcher 4 24%
Student > Master 2 12%
Professor 1 6%
Librarian 1 6%
Other 1 6%
Unknown 4 24%
Readers by discipline Count As %
Medicine and Dentistry 6 35%
Arts and Humanities 1 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Nursing and Health Professions 1 6%
Biochemistry, Genetics and Molecular Biology 1 6%
Other 2 12%
Unknown 5 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 232. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 March 2024.
All research outputs
#166,883
of 25,779,988 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#4
of 527 outputs
Outputs of similar age
#5,241
of 448,252 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#1
of 16 outputs
Altmetric has tracked 25,779,988 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 527 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.8. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,252 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.